Clinical Research Directory
Browse clinical research sites, groups, and studies.
HeadStART: Evaluating the Effectiveness of Community ART Delivery for People Newly Diagnosed With HIV
Sponsor: University of Washington
Summary
This is a cluster randomized controlled trial at 12 health centers in refugee settlements in Uganda aiming to evaluate effectiveness of expansion of community antiretroviral therapy (ART) delivery to people newly diagnosed with HIV in achieving HIV viral suppression.
Official title: Achieving HIV Viral Suppression in Refugee Settlements in Uganda With Head StART: A Cluster Randomized Trial Evaluating the Effectiveness of Community ART Delivery for People Newly Diagnosed With HIV
Key Details
Gender
All
Age Range
Any - Any
Study Type
INTERVENTIONAL
Enrollment
2720
Start Date
2024-01-15
Completion Date
2028-01-31
Last Updated
2025-01-09
Healthy Volunteers
No
Conditions
Interventions
Community Antiretroviral Therapy
Newly diagnosed individuals (diagnosed in the prior 6 months) at intervention sites will be offered community ART delivery on a rolling basis during the enrollment window, initiating individuals into groups as close to their date of diagnosis as possible. Newly enrolled individuals will join existing community ART delivery groups, or when a new group is needed based on group size or geographic location, a new group will be formed.
Locations (1)
Infectious Diseases Institute, Makerere University
Kampala, Uganda